Prognostic biomarker RASSF1 in head and neck squamous cell carcinoma.

Si, Yishimei; Meng, Linghan; Zhang, Bingwen; Qi, Jianwei

Si, Yishimei; Meng, Linghan; Zhang, Bingwen; Qi, Jianwei.

Affiliation

Si Y; Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: sysmah@163.com.
Meng L; Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: menglh7@163.com.
Zhang B; Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: zhangbingwen0101@163.com.
Qi J; Department of Otolaryngology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. Electronic address: qijianwei0202@163.com.

Asian J Surg ; 46(10): 4425-4427, 2023 10.

Article de En | MEDLINE | ID: mdl-37147256

Sujet(s)
Mots clés

Clinical features; HNSCC; Prognosis; RASSF1

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Carcinome épidermoïde / Tumeurs de la tête et du cou Type d'étude: Diagnostic_studies / Prognostic_studies Limites: Humans Langue: En Journal: Asian J Surg Année: 2023 Type de document: Article Pays de publication: Pays-Bas

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google